Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis.

Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial.

Signe Møller-Bisgaard, Bo Jannik Ejbjerg, Iris Eshed, Kim Hørslev-Petersen, Merete Lund Hetland, Anne Grethe Jurik, Jørgen Vallø, Henrik Thomsen, Trine Torfing, Kristian Stengaard-Pedersen, Peter Junker, Niels Steen Krogh, Tine Lottenburger, Torkell Ellingsen, Lis Smedegaard Andersen, Ib Hansen, Henrik Skjødt, Anders Jørgen Svendsen, Ulrik Tarp, Jan Pødenphant & 3 andre Jens Kristian Pedersen, Hanne Merete Lindegaard, Mikkel Ostergaard

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

OriginalsprogEngelsk
Publikationsdato2015
StatusUdgivet - 2015
BegivenhedACR/ARHP: American College of Rheumatology - San Francisco, USA
Varighed: 7. nov. 2015 → 11. nov. 2015

Konference

KonferenceACR/ARHP
LandUSA
BySan Francisco
Periode07/11/2015 → 11/11/2015

Citer dette

Møller-Bisgaard, Signe ; Ejbjerg, Bo Jannik ; Eshed, Iris ; Hørslev-Petersen, Kim ; Hetland, Merete Lund ; Jurik, Anne Grethe ; Vallø, Jørgen ; Thomsen, Henrik ; Torfing, Trine ; Stengaard-Pedersen, Kristian ; Junker, Peter ; Steen Krogh, Niels ; Lottenburger, Tine ; Ellingsen, Torkell ; Andersen, Lis Smedegaard ; Hansen, Ib ; Skjødt, Henrik ; Svendsen, Anders Jørgen ; Tarp, Ulrik ; Pødenphant, Jan ; Pedersen, Jens Kristian ; Lindegaard, Hanne Merete ; Ostergaard, Mikkel. / Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis. Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial. Abstract fra ACR/ARHP, San Francisco, USA.
@conference{0e49f0ce78e041aa8cc112e304661ed2,
title = "Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis.: Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial.",
author = "Signe M{\o}ller-Bisgaard and Ejbjerg, {Bo Jannik} and Iris Eshed and Kim H{\o}rslev-Petersen and Hetland, {Merete Lund} and Jurik, {Anne Grethe} and J{\o}rgen Vall{\o} and Henrik Thomsen and Trine Torfing and Kristian Stengaard-Pedersen and Peter Junker and {Steen Krogh}, Niels and Tine Lottenburger and Torkell Ellingsen and Andersen, {Lis Smedegaard} and Ib Hansen and Henrik Skj{\o}dt and Svendsen, {Anders J{\o}rgen} and Ulrik Tarp and Jan P{\o}denphant and Pedersen, {Jens Kristian} and Lindegaard, {Hanne Merete} and Mikkel Ostergaard",
year = "2015",
language = "English",
note = "null ; Conference date: 07-11-2015 Through 11-11-2015",

}

Møller-Bisgaard, S, Ejbjerg, BJ, Eshed, I, Hørslev-Petersen, K, Hetland, ML, Jurik, AG, Vallø, J, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Junker, P, Steen Krogh, N, Lottenburger, T, Ellingsen, T, Andersen, LS, Hansen, I, Skjødt, H, Svendsen, AJ, Tarp, U, Pødenphant, J, Pedersen, JK, Lindegaard, HM & Ostergaard, M 2015, 'Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis. Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial.' ACR/ARHP, San Francisco, USA, 07/11/2015 - 11/11/2015, .

Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis. Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial. / Møller-Bisgaard, Signe; Ejbjerg, Bo Jannik; Eshed, Iris; Hørslev-Petersen, Kim; Hetland, Merete Lund; Jurik, Anne Grethe ; Vallø, Jørgen; Thomsen, Henrik; Torfing, Trine; Stengaard-Pedersen, Kristian; Junker, Peter; Steen Krogh, Niels; Lottenburger, Tine; Ellingsen, Torkell; Andersen, Lis Smedegaard; Hansen, Ib; Skjødt, Henrik; Svendsen, Anders Jørgen; Tarp, Ulrik; Pødenphant, Jan; Pedersen, Jens Kristian; Lindegaard, Hanne Merete; Ostergaard, Mikkel.

2015. Abstract fra ACR/ARHP, San Francisco, USA.

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

TY - ABST

T1 - Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis.

T2 - Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial.

AU - Møller-Bisgaard, Signe

AU - Ejbjerg, Bo Jannik

AU - Eshed, Iris

AU - Hørslev-Petersen, Kim

AU - Hetland, Merete Lund

AU - Jurik, Anne Grethe

AU - Vallø, Jørgen

AU - Thomsen, Henrik

AU - Torfing, Trine

AU - Stengaard-Pedersen, Kristian

AU - Junker, Peter

AU - Steen Krogh, Niels

AU - Lottenburger, Tine

AU - Ellingsen, Torkell

AU - Andersen, Lis Smedegaard

AU - Hansen, Ib

AU - Skjødt, Henrik

AU - Svendsen, Anders Jørgen

AU - Tarp, Ulrik

AU - Pødenphant, Jan

AU - Pedersen, Jens Kristian

AU - Lindegaard, Hanne Merete

AU - Ostergaard, Mikkel

PY - 2015

Y1 - 2015

M3 - Conference abstract for conference

ER -

Møller-Bisgaard S, Ejbjerg BJ, Eshed I, Hørslev-Petersen K, Hetland ML, Jurik AG et al. Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis. Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial.. 2015. Abstract fra ACR/ARHP, San Francisco, USA.